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                                                    INTRODUCTION 
 
Periodontitis is an infectious, inflammatory disease that results in the destruction of the 
supporting hard and soft tissues around the teeth. Destruction of these teeth supporting structures 
especially alveolar bone is responsible for tooth loss. Bone tissue maintains its homeostasis by 
bone formation and resorption. This equilibrium is disrupted when resorption exceeds formation 
as in the case of periodontal disease. Bone resorption results in the alteration of its normal 
morphologic features.  According to Pritchard (1965) osseous defects caused by periodontal 
disease can be  interproximal craters, inconsistent margins, hemisepta, furca invasions, intrabony 
defects and combinations of those defects.
1
 Once the periodontal disease progresses, bone 
destruction extends to the furcation of multirooted teeth to cause furcation involvement. 
Complexity of furcation morphology often causes difficulty in the treatment of such 
defects. Routine home care measures and periodontal procedures may not be sufficient enough to 
keep the furcation area free of local factors and therefore specialized procedures are required.
 
  Several resective and reconstructive treatment modalities have been developed to treat 
furcation involvement such as furcation plasty, root resection, hemisection, bone grafting, guided 
tissue regenerative procedures or a combination therapy. Selection of different procedures is 
based on the extent of furcation involvement. 
The primary goal of periodontal therapy is the reconstruction of the lost or injured parts 
of the periodontium, i.e. to restore the normal structure and function of the periodontium by 
formation of new bone, cementum and periodontal ligament. The biologic principal of guided 
tissue regeneration is based on the Melcher’s concept of repair of periodontal tissues, which 
                                                                                                                                        Introduction 
 
2 
 
describes periodontal ligament cells as the only type of cells that can regenerate the entire 
attachment apparatus. The use of a barrier membrane can isolate the periodontal ligament cells 
and prevent the other cells from repopulating the root surface, which is necessary for successful 
periodontal regeneration.
2 
Investigations have proven that using bone replacement grafts for the treatment of 
furcation defects results in the reduction of probing pocket depth, gain of clinical attachment 
level and bone level and density. 
 The bone replacement graft can be an autograft, allograft, xenograft or alloplast. The 
synthetic bone substitute i.e. alloplasts have numerous advantages over other materials  like, 
unlimited availability, storage potential, no risk of disease transmission and no need for second 
surgical site. Novabone putty is a bioactive synthetic calcium phosphosilicate bone graft material 
with osteoconductive and osteostimulative properties that can accelerate the bone regeneration. 
Platelet Rich Fibrin (PRF) is a second generation platelet concentrate with inherent 
advantages over Platelet Rich Plasma (PRP). This fibrin clot can be manipulated into a dense 
fibrin matrix membrane that can be trimmed, adapted and sutured easily. The presence of high 
amount of growth factors such as TGF 1β, VEGF, PDGF in PRF assists in wound healing and 
promotes tissue regeneration making it an excellent barrier membrane in the treatment of 
furcation defects.
3 
The present study was undertaken to clinically and radiographically evaluate the efficacy 
of platelet rich fibrin (PRF) membrane in augmenting the effect of Novabone putty bone 
replacement graft in the regeneration of Grade II furcation involvement as compared to the 
treatment with bone replacement graft alone. 
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AIMS AND OBJECTIVES 
1. To estimate the effectiveness of Novabone putty bone replacement graft in the treatment 
of mandibular molar Grade II furcation defects. 
2. To estimate the effectiveness of Novabone putty with a combination of PRF  in the 
treatment of mandibular molar grade II furcation defects. 
3. To assess the effectiveness of platelet rich fibrin in augmenting the regenerative effect of 
Novabone putty bone replacement graft clinically and radiographically. 
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                                                    REVIEW OF LITERATURE 
Chronic inflammatory periodontal disease leads to changes in the architecture of the 
normal alveolar bone. Glickman (1964) describes the bone deformities due to periodontal 
disease as osseous craters, infrabony defects, bulbous bone contours, hemisepta, inconsistent 
gingival margins and ledges.
1 
The furcation is an area of complex anatomic morphology that may be difficult or 
impossible to debride by routine periodontal instrumentation. The progress of inflammatory 
periodontal disease if unabated, ultimately results in attachment loss sufficient enough to 
affect the bifurcation or trifurcation of multirooted teeth.
 
Furcation defects are currently managed/treated through regenerative procedures or 
resective procedures like furcationplasty, tunnel operation, hemisection, root resection, 
regeneration or extraction.
 
THE CONCEPT OF PERIODONTAL RECONSTRUCTION 
According to AH Melcher, regeneration of periodontal ligament is of prime 
importance as it provides continuity between the alveolar bone and the cementum and also it 
apparently contains cells that can synthesize and remodel the three connective tissues of the 
alveolar part of the periodontium.
2 
Periodontal reconstructive therapy has multiple facets like bone grafts, GTR, growth 
factors, enamel matrix proteins, bone morphogenetic proteins and platelet concentrates. The 
use of bone grafts in reconstructive periodontal therapy is based on the assumption that, they 
can help to restore the alveolar bone lost due to periodontal disease. 
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BIOACTIVE GLASS 
Among the several alloplastic bone graft materials commercially available, Bio-active 
glass has been substantially used for several years. Bio-active glass ceramics were first 
developed by Hench et al in 1971. This material can be used alone or in combination with 
autogenous and allogenous bone grafts. Bioglass is composed mainly of silica, sodium oxide, 
calcium oxide and phosphates. This glass is biocompatible, osteoconductive and bonds to the 
bone without an intervening fibrous connective tissue interface. 
The bone-bonding reaction results from a sequence of reactions in the glass and its 
surface. After long-term implantation, this biological apatite layer is partially replaced by 
newly formed bone. The behaviour of bioactive glasses is governed by the composition of the 
glass, the surrounding pH, the temperature and the surface layers on the glass. The porosity 
provides a scaffold which facilitates vascular ingrowth, osteoblast differentiation and new 
bone deposition. It is also beneficial for resorption and bioactivity.
4 
PLATELET RICH FIBRIN  
Platelet rich fibrin refers to a second generation therapeutic platelet concentrate, the 
first being the platelet rich plasma. PRF was first described by Choukroun et al. in the year 
2001.The use of this platelet concentrate during reconstructive surgery helps in several ways. 
First, the PRF membrane protects and maintains the grafted material and its fragments 
serving as a biological connector between the bone graft materials. 
Second, the integration of this fibrin network into the regenerative site helps in cellular 
migration, mainly for endothelial cells required for the neo-angiogenesis, vascularization and 
survival of the graft. 
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Third, the platelet cytokines such as PDGF, TGF- β, IGF-1 are gradually released as the 
fibrin matrix is resorbed, thus creating a perpetual process of healing. 
Lastly, the presence of leukocytes and cytokines in the fibrin meshwork plays a significant 
role in the self-regulation of the inflammatory and infectious phenomena within the grafted 
material.
3 
 
Zamet et al. (1997)
 5
 investigated the effect of Perioglas in the treatment of periodontal 
intrabony defects in 22 patients with at least two defects in the posterior segments. The 
defects were treated either with open flap debridement and Perioglas or by open flap 
debridement alone. Plaque score, bleeding score, probing pocket depth, probing attachment 
level and gingival recession were measured at baseline, 3, 6, 9 months and 1 year post 
surgery. Radiographic bone density was evaluated using computer assisted densitometric 
analysis in standardized radiographs. Results revealed that probing pocket depth and probing 
attachment level showed significant improvements in both groups with a greater trend 
towards improvement in the Perioglas treated sites with a significant defect fill than the sites 
treated with debridement alone. They concluded that bioactive glass is an effective adjunct to 
conventional surgery in the treatment of intrabony defects.
 
 
Froum et al. (1998)
 6
 evaluated the effectiveness of bioactive synthetic bone particles in 
the treatment of periodontal intrabony or furcation defects. Fifty nine defects in 16 subjects 
were treated with bioactive glass or with open flap debridement alone. Clinical parameters 
such as probing depth, clinical attachment level, gingival recession and radiographic 
measurements were recorded at baseline, 6, 9 and 12 months. A significant reduction in PPD, 
gain in clinical attachment level and significantly greater radiographic defect fill were seen in 
the bioactive glass implanted site than the sites treated with debridement alone. Similarly re-
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entry after 12 months also showed significantly greater defect fill in the bioactive glass sites 
compared to control sites suggesting the efficacy of bioactive glass in osseous regeneration.
 
 
Lovelace et al. (1998)
 7
 investigated the effect of bioactive glass in the treatment of 
human periodontal defects in comparison with Demineralised Freeze Dried Bone allograft. 
Paired vertical osseous defect in 15 patients were treated with either one of the test materials. 
Soft tissue measurements such as gingival recession, probing depth, clinical attachment level 
were evaluated at baseline and 6 months post operatively. Hard tissue measurements 
including defect depth, CEJ to base of the defect were taken at the time of surgery and at 6 
months re-entry procedure. They concluded that both treatments resulted significant 
improvements in hard and soft tissue parameters, compared to baseline and no significant 
difference was observed between bioactive glass and Demineralised Freeze Dried Bone 
allograft.
 
 
Ong et al. (1998)
 8
 evaluated the regenerative effect of bioactive glass alloplast in 14 
patients with contra lateral periodontal intrabony defects. Defects were treated with bioactive 
glass along with open flap debridement or with open flap debridement alone. Clinical 
measurements such as probing depth, mobility, clinical attachment level were measured at 
baseline and 9-13 months post surgery. Hard tissue parameters including measurement of the 
defect depth and defect width were done intra-surgically and at the time of re-entry. The 
results of the study revealed that bioactive glass treated sites showed significant probing 
depth reduction and clinical attachment level gain. Re-entry after 9- 13 months showed 
significant improvement in hard tissue parameters for the test and control sites when 
compared with baseline and no significant intergroup differences were found.
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  Anderegg et al. (1999)
 9
 investigated the effect of bioactive glass particulate in the 
treatment of molar class II furcation  in 15 patients with defects in adjacent first and second 
mandibular molars. One site was treated with bioactive glass and the other with open flap 
debridement alone. Clinical measurements such as probing depth, clinical attachment level 
were measured before surgery and at 3 and 6 months post surgery. Defects treated with 
bioactive glass showed significant improvement in terms of clinical parameters suggesting 
the potential additional clinical benefits of bioactive glass over open flap debridement alone.
 
 
Nevins et al. (2000)
 10
 histologically evaluated the healing of Bioactive Glass ceramic 
(Perioglas) in periodontal osseous defects. Intrabony defects around 5 teeth with poor 
prognosis were treated with Perioglas and with e-PTFE. Clinical measurements including 
probing pocket depth, recession, relative attachment level and radiographs were obtained at 
baseline and at 6 months. Block biopsies were obtained 12 months after treatment for 
histologic evaluation. Results of the study revealed favourable clinical outcomes and 
radiographic evidence of radio opacities. Histologic sections showed that the new bone 
formation was limited to the most apical borders of the defects and no signs of periodontal 
regeneration as defined by new cementum, PDL and bone formation. They have concluded 
that bioactive glass ceramic has only limited regenerative properties.
 
 
Yukna et al. (2001)
 11
 studied the effects of bioactive glass replacement graft and ePTFE 
in the treatment of mandibular molar class II furcation. Twenty seven pairs of mandibular 
molars in 27 patients were treated with bioactive glass or ePTFE membrane.  Clinical 
measurements such as gingival recession, probing depth, clinical attachment level at baseline 
and 6 months post operatively were evaluated. Horizontal depth of the furcation was 
measured at the time of surgery and at 6 months re-entry period. They found that both 
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treatments resulted in significant defect fill, with no significant difference between the groups 
and concluded that the bioactive glass and e-PTFE are equally effective in the treatment of 
mandibular molar Class II furcation.
 
 
Stavropoulos et al. (2003)
 12
 in an experimental study evaluated the influence of the 
Deproteinized bovine bone (Bio-Oss) or Bioactive glass (Biogran) on bone formation along 
with GTR in 18 albino rats. Defects were created surgically in the lateral aspect of the 
mandibular ramus and the defects were filled with rigid, hemispherical Teflon capsules 
packed with Deproteinized bovine bone or Bioactive glass or empty capsules. One year after 
the experimental period the animals were sacrificed and the specimens were histologically 
evaluated for the new bone formation. They found that only limited bone formation occurred 
for the test materials and no signs of ongoing bone formation in any of the treated area.  Due 
to the lack of active bone formation in all the test specimens, they have concluded that Bio-
Oss and Biogran with GTR does not promote but rather arrest bone formation.
 
 
Mengel et al. (2006)
 13
 investigated the effectiveness of bioabsorbable membrane (Resolut 
XT) and bioactive glass (PerioGlas) in the treatment of 42 intrabony defects in sixteen 
patients with generalised aggressive periodontitis. The defects were treated with either 
bioabsorbable membrane or with bioactive glass. Clinical parameters such as probing depth, 
mobility, gingival recession, clinical attachment level and radiographic evaluation of the 
defect depth were done at baseline, 6 months and every year for 5 years. Five year results 
after the surgical intervention showed highly significant reduction in probing depth and gain 
in CAL with no significant intergroup differences. They have concluded that the long term 
stability of bioabsorbable membrane and bioactive glass makes them suitable materials for 
the treatment of intrabony defects in generalised aggressive periodontitis patients.
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Pontes et al. (2006)
 14
 investigated the influence of bioactive glass and Enamel matrix 
derivative in surgically created Class II furcation defects in mongrel dogs. Defects were 
created in second, third and fourth premolar and treated with bioactive glass with enamel 
matrix derivative or bioactive glass alone. Animals were sacrificed 12 weeks after the 
treatment and subjected to histomorphometric analysis to evaluate the extension of 
epithelium, extension of new cementum, extension of the connective tissue and area of bone 
fill. The results revealed that both materials have the potential to improve periodontal 
regeneration and combination of bioactive glass with Enamel matrix derivative favours new 
cementum formation.
 
 
Tsao et al. (2006) 
15
 investigated the factors influencing treatment outcomes in 
mandibular Class II furcation defect in 20 subjects. Clinical parameters such as plaque index, 
bleeding on probing, probing depth, clinical attachment level, recession and mobility were 
evaluated at baseline and 6 months post operatively. The horizontal and vertical defect depths 
were measured intra surgically and at 6 months re-entry surgeries. They found that except for 
the initial vertical defect depth no other factors such as anatomic, clinical parameters or 
background factors (smoking status, surgeon’s experience and endodontic status) have any 
effect in the treatment outcome. In addition the study revealed the “treatment modality” as a 
major influencing factor.
 
 
Kuru et al. (2006)
 16
 investigated the effect of Enamel matrix derivative (EMD) alone or 
in combination with a bioactive glass in the treatment of wide intrabony defects. 23 patients 
having one intra bony defect were treated with either EMD + bioactive glass or with EMD 
alone. Clinical parameters including plaque index, sulcus bleeding index, relative attachment 
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level, probing depth and marginal recession and radiographic evaluation of bone level were 
recorded at baseline and 8 months post operatively. They found that the combination 
treatment yielded more favourable clinical and radiographic outcomes when compared to 
treatment with EMD alone. The authors suggest the use of combined treatment to enhance the 
periodontal regeneration.
 
 
Humagain et al. (2007)
 17
 investigated the effect of bioactive glass particulate (PerioGlas) 
in the treatment of mandibular class II furcation defects. 20 mandibular molar class II 
furcation defects were selected and the defects were treated by open flap debridement with 
bioactive glass particulate or by open flap debridement alone. Soft tissue parameters such as 
vertical probing depth, horizontal probing depth, clinical attachment level and gingival 
recession were measured at baseline and six months post surgery. Hard tissue parameters 
included vertical depth of the furcation (furcation fornix to base of furcation) and horizontal 
depth of the furcation (horizontally deepest part of the furcation). The results revealed no 
significant difference in clinical parameters for both treatment groups. Vertical defect fill was 
significantly greater in the sites treated with bioactive glass than control sites. They 
concluded that open flap debridement alone and bioactive glass with open flap debridement  
were effective in the treatment of class II furcation defects and the combined treatment 
showed significant improvement in vertical and horizontal defect fill compared to open flap 
debridement alone.
 
 
Demir et al. (2007)
 18
 investigated the effect of bioactive glass graft material with and 
without Platelet rich plasma on the clinical healing of intrabony defects. 29 patients with an 
intrabony defect were treated with platelet rich plasma plus bioactive glass or with bioactive 
glass alone. Clinical evaluation of plaque index, gingival index, bleeding on probing, clinical 
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attachment level, probing depth and gingival recession were done at baseline and 9 months 
post treatment. Intra-surgical measurements of depth of intrabony defect, distance from CEJ 
to base of defect and to crest of the defect were done and repeated at 9 months re-entry. The 
results revealed that both treatments were effective in probing pocket depth reduction, CAL 
gain and defect fill, with no significant difference between the group. They concluded that 
using platelet rich plasma along with bioactive glass has no additional effect in the healing of 
the intrabony defect.
 
 
Cetinkaya et al. (2007)
 19
 investigated the proliferative activity of gingival epithelium 
after surgical treatment of intrabony defects with bioactive glass and bioabsorbable 
membrane. 10 patients having two identical intrabony defects were treated with bioactive 
glass or with bioabsorbable membrane. Gingival biopsies were obtained 12 weeks after 
treatment and proliferative activity was analysed using proliferating cell nuclear antigen 
(PCNA) as a marker in immunohistochemically stained sections. They found that epithelial 
cell proliferation is more prominent after treatment of intrabony defects with bioactive glass 
compared to the treatment with bioabsorbable membrane.
 
 
Dybvik et al. (2009)
 20
 investigated the efficacy of bioactive ceramic filler with open flap 
debridement in the treatment of deep intra osseous defect and compared it with open flap 
debridement alone. 19 patients with one interproximal defect were selected for the study and 
12 defects received bioactive ceramic filler and 7 defects received open flap debridement 
alone. At baseline, 6 and 12 months, clinical parameters such as bleeding on probing, probing 
depth and probing attachment level were assessed and standardized periapical radiographs 
were taken to evaluate the bone level from CEJ to apical extent of osseous defect. The results 
revealed that one year post operative gain in CAL, reduction on probing depth and 
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radiographic bone levels following flap surgery with a bioactive glass were not significantly 
different from treatment outcome following flap surgery alone. They concluded that the use 
of bioactive ceramic filler added no significant benefit over open flap debridement alone in 
the treatment of teeth with deep intraosseous defect.
 
 
Emilia et al. (2009)
 21
 conducted a histologic and histometric analysis to evaluate the 
potential of bioactive glass particles of different size ranges in bone formation of two wall 
intrabony defects in 6 dogs. 2 wall intrabony defects were surgically created on the mesial 
surface of mandibular 3
rd
 premolars and first molars bilaterally. The defects were treated with 
bioabsorbable membrane along with bioactive particle sizes of 300-355µm or between 90-
710 µm, membrane alone or negative control. 12 weeks after the treatment dogs were 
sacrificed and histomorphometric analysis were made and evaluated for the areas of newly 
formed bone, new mineralized bone and bioactive glass particle remnants. The results 
revealed that bioactive glass remnants were found more in defects treated with larger particle 
sizes and the areas of new mineralized bone were found in the defects treated with 
bioabsorbable membrane with bioactive glass compared with defects treated with membrane 
alone. They have concluded that bioactive glass particles of small sizes of 300-350 µm range 
underwent faster resorption and substitution by new bone than larger particles of 90-710 µm 
sizes.
 
 
Kaur et al. (2010)
 22
 investigated the regenerative potential of a combination of Platelet 
rich plasma and bioactive glass and Bioactive glass alone in the treatment of periodontal 
intrabony defects in 10 patients with bilateral defects. Test sites received a combination of 
Platelet rich plasma and bioactive glass and control sites received bioactive glass alone. 
Clinical parameters like probing pocket depth, clinical attachment level, gingival recession 
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and radiographic evaluation of the defect depth were recorded at baseline, 3 and 6 months 
post operatively. Clinical and Radiographic evaluation 6 months post treatment showed 
significant difference in all parameters from baseline with no significant difference between 
the groups. Additional use of Platelet rich plasma has led to slight improvement in CAL gain 
in test group, attributed to the potential of Platelet rich plasma in soft tissue healing. The 
authors have concluded that the combination of Platelet rich plasma with a bioactive glass 
graft has added some benefits to the improvement of clinical parameters in the treatment of 
intrabony defects. 
 
Ehrenfest et al. (2010)
 23
 investigated the three - dimensional architecture of Platelet rich 
fibrin and evaluated the influence of different collection tubes (dry glass or glass coated 
plastic tubes) and compression procedures (forcible or soft) on the final Platelet rich fibrin 
architecture. Blood samples were collected from 10 healthy subjects and the platelet rich 
fibrin was prepared by centrifuging the collected blood at 3000 rpm for 10 minutes. The 
Platelet rich fibrin clots and membrane were histologically processed for examination by light 
microscopy and scanning electron microscopy. The results revealed that the preparation 
protocol concentrated most platelets and leukocytes from a blood harvest into a single 
autologous fibrin biomaterial. The study also showed that the type of the test tube (dry or 
glass coated plastic tubes) and the compression procedures of clot did not influence the 
architecture of the platelet rich fibrin.
 
 
Yadav et al. (2011)
 24
 investigated the clinical outcomes of collagen membrane (GTR) 
alone, in combination with autogenous graft and autogenous graft mixed with bioactive glass 
in the treatment of 32 periodontal intrabony defects in 22 patients. The defects were treated 
with bioresorbable collagen membrane or autogenous bone graft covered by collagen 
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membrane or autogenous graft mixed with bioactive glass covered by collagen membrane. 
Clinical parameters such as probing depth, clinical attachment level and radiographic 
measurement of defect depth were recorded at baseline and at 6 months post operatively. A 
significant PPD reduction, CAL gain and defect resolution was observed after a period of 6 
months for all the groups. They found similar improvement in clinical parameters with GTR 
with autogenous bone graft and autogenous bone graft mixed with bioactive glass and 
concluded that autogenous bone graft can be mixed with bioactive glass if the amount of the 
harvested bone is not sufficient.
 
 
Gonshor et al. (2011)
 25
 investigated the effect of calcium-phosphosilicate putty 
(Novabone putty) as a grafting material in 22 post-extraction alveolar sockets. Teeth were 
extracted and the sockets were filled immediately with 0.5cc-1.0cc of calcium-
phosphosilicate putty material. Core biopsies were obtained at the time of implant placement 
and processed for histomorphometric evaluation. Radiographic evaluation 6 months after 
grafting showed substantial bone fill in the sockets and the trabecular pattern in the 
regenerated area appeared similar to the native bone. Histomorphometric evaluation showed 
mature trabecular bone with osteocytes in the lacuna as well as marrow formation within the 
new bone structure. They concluded that calcium-phospho-silicate putty can be a reliable 
choice for osseous regeneration in cases of crest preservation and implant related surgeries.
 
 
Sharma et al. (2011)
 26
 evaluated the effect of Platelet rich fibrin in the treatment of 
mandibular degree II furcation defects. 18 patients with contralateral buccal Degree II 
furcation defects were treated either with platelet rich fibrin along with open flap 
debridement or with open flap debridement alone. Clinical parameters including probing 
depth, clinical attachment level, gingival margin level and radiographic parameters were 
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evaluated at baseline and 9 months post operatively. Standardized periapical radiographs 
were used to measure the distance from the furcation fornix to the base of the defect. The 
results of the study showed significant improvement in all the clinical and radiological 
parameters at the sites treated with platelet rich fibrin compared to open flap debridement 
alone. They concluded that platelet rich fibrin is effective in the regenerative treatment of 
furcation defects.
 
 
Sharma et al. (2011) 
27 
investigated the effect of Platelet rich fibrin in the treatment of 3 
wall intrabony defects. Fifty six intrabony defects in 42 patients were treated with either 
autologous platelet rich fibrin along with open flap debridement or with open flap 
debridement alone. Platelet rich fibrin was filled into the intrabony defect and covered by 
platelet rich fibrin membrane. Clinical parameters measured at baseline and 9 months post 
operatively included probing depth, periodontal attachment level and gingival margin level. 
For the measurement of bone defect radiographically, the distance from the crest of the 
alveolar bone to the base of the defect was considered. Results of the study revealed that 
significant improvement in clinical parameters at the sites treated with Platelet rich fibrin 
compared to sites treated with open flap debridement alone. Similarly radiographic evaluation 
showed significant defect fill favouring the platelet rich fibrin treated sites. They concluded 
that PRF has excellent properties to enhance periodontal wound healing substantiating the use 
of PRF in the treatment of intrabony defects.
 
 
Chang et al. (2011)
 28
 investigated the effects of Platelet rich fibrin on human periodontal 
ligament fibroblast and its application for reconstruction of periodontal intrabony defects. 
Periodontal ligament fibroblast was obtained from healthy individuals undergoing extraction 
for orthodontic reasons.  The effect of Platelet rich fibrin on periodontal ligament fibroblast 
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was determined by measuring the expression of extracellular signal related protein kinase (p-
ERK), osteoprotegerin (OPG) and alkaline phosphatase activity (ALP). The results of the 
study revealed that Platelet rich fibrin increases the extracellular signal related protein kinase 
(p-ERK), osteoprotegerin (OPG) and alkaline phosphatase activity (ALP). They have 
concluded that p-ERK, OPG and ALP expression by Platelet rich fibrin provides benefits for 
periodontal regeneration and the application of Platelet rich fibrin in intrabony defects 
showed significant clinical and radiographic improvement suggesting the use of Platelet rich 
fibrin as an effective treatment modality for periodontal intrabony defects.
 
 
Tavakoli et al. (2012)
 29
 conducted an in vitro experimental study to investigate the 
genotoxicity effects of Nano bioactive glass and Novabone Bioglass on gingival fibroblasts. 
Periodontal C165 fibroblast cells were cultured and the genotoxicity of the materials were 
evaluated at different concentration using Comet assay test. They found that novel Nano 
bioactive glass had no genotoxicity in concentrations lower than 4mg/ml and Novabone 
bioglass did not showed genotoxicity event at concentration higher than 4mg/ml, whereas 
nanoparticles showed a higher level of genotoxicity.
 
 
Pradeep et al. (2012) 
30 
compared and evaluated the effect of autologous Platelet rich 
fibrin and Platelet rich plasma in the treatment of 3 wall intrabony defects. 90 intrabony 
defects in 56 subjects were treated either with autologous platelet rich fibrin and open flap 
debridement or autologous platelet rich plasma and open flap debridement or open flap 
debridement alone. Clinical parameters such as probing depth, clinical attachment level and 
radiologic evaluation of the distance from the crest of the bone to the base of the defect were 
recorded at baseline and 9 months post operatively. They found that significant improvement 
occurred in terms of all clinical and radiological parameters for the sites treated with 
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autologous Platelet rich fibrin and Platelet rich plasma compared to sites treated with open 
flap debridement alone. The authors concluded that Platelet rich fibrin preparation is less time 
consuming and less technique sensitive and therefore a better option than Platelet rich 
plasma.
 
 
Pradeep et al. (2012)
 31
 evaluated the effect of a combination of Porous hydroxyapatite 
graft with platelet rich fibrin for the treatment of 3 wall intrabony defects. 90 intrabony 
defects in 62 subjects were treated with autologous platelet rich fibrin with open flap 
debridement or platelet rich fibrin + hydroxyapatite graft with open flap debridement or open 
flap debridement alone. Clinical and radiographic parameters such as probing pocket depth, 
clinical attachment level, intrabony defect depth and percentage of defect fill were measured 
at baseline and 9 months postoperatively. The results of the study revealed that, treatment 
with Platelet rich fibrin + open flap debridement and platelet rich fibrin + hydroxyapatite 
with  open flap debridement  provided significant improvements in probing depth, clinical 
attachment level compared to open flap debridement alone. Similarly radiographic defect fill 
was significantly greater for the sites treated with test materials than control sites. The 
addition of hydroxyapatite with Platelet rich fibrin was found to increase the regenerative 
effect observed with Platelet rich fibrin alone.
 
 
Wadhawan et al. (2012)
 32
 compared the efficacy of non-resorbable (Gore-Tex) 
membrane and bioabsorbable (Resolut Adapt) barrier membrane in combination with 
bioactive glass in the treatment of periodontal intrabony defects in 10 subjects with bilateral 
defects. Clinical parameters such as plaque index, gingival index, probing pocket depth, 
clinical attachment level, gingival recession and radiographic measurements using Computer 
Assisted Densitometric Image Analysis were recorded at baseline and 9 months post 
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operatively. Both non-resorbable membrane + Perioglas and bio absorbable membrane + 
Perioglas showed significant improvement in clinical parameters like probing depth 
reduction, CAL gain and Computer Assisted Densitometric Image Analysis(CADIA) also 
showed significant radiographic bone fill. Re-entry surgery during 9 months post treatment 
follow up also showed significant defect fill. Both barrier membranes were equally effective 
in enhancing periodontal regeneration signifying the role of GTR in periodontal regeneration.
 
 
Jankovic et al. (2012)
 33
 evaluated the effect of Platelet rich fibrin membrane with 
coronally advanced flap in the treatment of gingival recession and compared it with 
connective tissue graft along with coronally advanced flap. 15 patients having bilateral 
defects were treated with Platelet rich fibrin membrane with coronally advanced flap on one 
side and other side with connective tissue graft along with coronally advanced flap. Clinical 
parameters such as recession depth, keratinized tissue width, probing depth, clinical 
attachment level were recorded at baseline and at 6 months post operatively. The results of 
the study showed that use of Platelet rich fibrin membrane provided acceptable clinical 
results, enhanced wound healing and reduced patient discomfort compared to the treatment 
with connective tissue graft. They concluded that no difference were found between the 
groups , except for a greater gain in keratinized tissue width obtained for connective tissue 
group and enhanced wound healing obtained for the Platelet rich fibrin group.
 
 
Katuri et al. (2013) 
34 
investigated the effect of bioactive glass alloplast and DFDBA 
allograft in the treatment of periodontal intraosseous defect in 12 patients with contralateral 
vertical osseous defects and treated with bioactive glass or with DFDBA. Clinical and 
radiographic evaluation was carried out at baseline, 6 months and 12 months. The results 
revealed that sites treated with DFDBA exhibited statistically significant improvement in 
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clinical parameters such as probing pocket depth reduction and clinical attachment level gain 
compared to sites treated with bioactive glass. Similarly standardized periapical radiographs 
measured using millimeter grid also showed significant radiographic defect fill at DFDBA 
treated sites. They concluded that DFDBA offers more benefits than bioactive glass in the 
treatment of periodontal intraosseous defects.
 
 
Grover et al. (2013) 
35 
evaluated the efficacy of bioactive synthetic bone graft (Novabone 
dental Putty) in the treatment of intrabony periodontal defects. Fourteen intrabony defects in 
12 chronic periodontitis subjects were treated with bioactive ceramic filler. Clinical 
parameters and radiographic evaluation of the depth of intrabony defect were measured at 
baseline, 3 and 6 months post surgery. The result of the study revealed that treatment of 
intrabony periodontal osseous defects with Novabone dental putty led to statistically 
significant probing depth reduction, relative attachment level gain and radiographic osseous 
defect fill compared to baseline measurements. They concluded that bioactive glass is an 
effective treatment option in the reconstruction of intrabony periodontal defects. 
 
Padma et al. (2013) 
36 
investigated the adjunctive effect of platelet rich fibrin along with 
coronally advanced flap in the treatment of identical bilateral isolated Millers class I or class 
II gingival recession in 15 patients. Defects were treated either with a combination of 
coronally advanced flap along with platelet rich fibrin or with coronally advanced flap alone. 
Recession depth, clinical attachment level and width of keratinized gingiva were measured at 
baseline, 1, 3 and 6 months post surgery. The results of the study revealed that combination 
treatment showed statistically significant clinical outcomes compared to control sites. They 
concluded that Platelet rich fibrin membrane with coronally advanced flap provides superior 
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root coverage with additional benefits of gain in clinical attachment level and width of 
keratinized gingiva.
 
 
Bajaj et al. (2013)
 37
 investigated and compared the additional efficacy of autologous 
Platelet rich fibrin (PRF) and Platelet rich plasma (PRP) with open flap debridement (OFD) 
in the treatment of mandibular degree II furcation defects.  72 buccal mandibular degree II 
furcation defects in 42 patients were treated with either autologous platelet rich fibrin with 
open flap debridement or autologous platelet rich plasma with open flap debridement or open 
flap debridement alone. Clinical parameters such as probing depth, relative vertical and 
horizontal clinical attachment level and radiographic evaluation of bony defect were recorded 
at baseline and 9 month postoperatively. Bone defect was measured from furcation fornix to 
the base of the defect was considered. The results of the study revealed that the sites treated 
with platelet rich fibrin and Platelet rich plasma showed significant improvement in all 
clinical parameters compared to OFD alone. Similarly radiological parameters also showed 
significant defect fill for the site treated with test materials than control sites. They concluded 
that autologous rich fibrin and Platelet rich plasma are two regenerative materials that can be 
used in the treatment of furcation defects.
 
 
Bansal et al. (2013) 
38 
investigated the efficacy of Demineralized freeze dried bone 
allograft (DFDBA) combined with Platelet rich fibrin in the treatment of periodontal 
intrabony defects. 10 patients with bilateral identical intrabony defects were treated with 
Demineralized freeze dried bone allograft alone or Demineralized freeze dried bone allograft 
combined with Platelet rich fibrin.  Clinical and radiographic parameters were recorded at 
baseline and at 6 months post operatively. Radiographic measurements included the distance 
from CEJ to the base of the defect, distance from CEJ to the alveolar crest and distance from 
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alveolar crest to the base of the defect. The results revealed significant radiographic defect fill 
and defect resolution for both treatment groups and combination therapy provided better 
results in terms of probing pocket depth reduction, gain in clinical attachment level compared 
to treatment with Demineralized freeze dried bone allograft alone, suggesting the 
regenerative potnetial of platelet rich fibrin in periodontal wound healing.
 
 
Penteado et al. (2013)
 39 
investigated the effectiveness of Platelet rich plasma and 
bioactive glass for bone healing in surgically created defects in rabbits. The defects were 
treated with bioactive glass or platelet rich plasma or with combination of platelet rich plasma 
and bioactive glass or blood clot only. The animals were sacrificed 12 weeks after treatment 
and the specimens were analysed radiographically for the percentage of bone density and 
histomorphometrically for the new bone formation. Results revealed that platelet rich plasma 
treated sites showed greater bone density than the groups not treated with platelet rich 
plasma.  They found that, Platelet rich plasma improved bone repair and that bioactive glass 
alone or in combination or in association with platelet rich plasma did not improve bone 
healing.
 
 
Abd EI-Meniem et al. (2014)
 40
 compared the efficacy of bioactive glass graft material 
with autogenous bone graft in the treatment of Grade II furcation involvement. A total of 30 
patients having buccal mandibular molar furcation defects were selected and treated either 
with bioactive glass or autogenous bone graft. Clinical parameters including probing pocket 
depth, clinical attachment level, assessment of furcation involvement using Naber’s probe, 
tooth mobility and standardized periapical radiographs were evaluated at baseline, 3 and 6 
months post surgically. Radiographs were digitized and a specially developed Visual Basic 
programme was developed to detect the furcation surface area and the mean gray level for the 
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selected area.  The study revealed that a significant improvement in all clinical parameters 
such as reduction in probing pocket depth, gain in CAL, less gingival recession, improvement 
in tooth mobility and  reduction in furcation surface area with an increase in the grey scale 
level in both groups with no statistically significant difference between them. The authors 
concluded that both are effective in the regenerative treatment of Grade II furcation 
involvement with bioactive glass having advantage of no need for a second surgical site.
 
 
Lakshmi et al. (2014)
 41
 evaluated the effectiveness of a combination of Platelet rich fibrin 
and bioactive glass, Platelet rich plasma and bioactive glass and bioactive glass alone in the 
treatment of 30 intrabony defects in 17 patients. Clinical parameters including probing depth, 
clinical attachment level and marginal recession were measured at baseline, 3, 6 and 9 
months post operatively. Depth of the bone defect was measured in standardized periapical 
radiographs with grid in position. The results revealed that the treatment of intrabony defects 
with test materials showed significant probing pocket depth reduction, clinical attachment 
level gain and radiographic bone gain compared to baseline measurements and that Platelet 
rich fibrin and Platelet rich plasma appear to have nearly comparable effects in periodontal 
regeneration, with Platelet rich fibrin displaying slightly superior effect compared to Platelet 
rich plasma, which in turn displayed superior efficacy than bioactive glass alone.
 
 
Asmita et al. (2014)
 42
 compared the putty form of bioactive glass (Novabone Dental 
Putty) with particulate form of bioactive glass (Perioglas) in the treatment of mandibular 
Class II furcation defects. 40 sites in 28 patients having class II furcation defects were treated 
either with Perioglas or with novabone putty material. Clinical and radiographic 
measurements were recorded at baseline and at 6 months. Radiographic assessment of the 
defect fill was carried out using CBCT. The results of the study showed significant reduction 
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in probing pocket depth, gain in CAL and reduction in vertical depth of furcation for both 
materials with no significant intergroup difference. Perioglas particulate material showed 
better results than Novabone putty in horizontal defect fill of the furcation. They have 
concluded that putty form was comparable to particulate form for resolution of Class II 
furcation defects.
 
 
Chacko et al. (2014)
 43
 evaluated the regenerative potential of Perioglas in 10 patients 
with 20 intrabony defects and compared it with open flap debridement. Evaluation of clinical 
and radiographic parameters was carried out at baseline, 6 and 9 months post-operatively. 
The results revealed significant improvement in all the parameters investigated from baseline 
to 9 months. On intergroup comparison, no significant difference was noted. Radiographic 
evaluation showed greater defect fill for the sites treated with Perioglas than sites treated with 
debridement alone.
 
 
Tamaraiselvan et al. (2015)
 44 
 investigated the adjunctive benefit of Platelet rich fibrin 
along with coronally advanced flap in the treatment of isolated Millers class I or class II 
buccal gingival recession in 20 patients. Defects were treated either with coronally advanced 
flap along with platelet rich fibrin or with coronally advanced flap alone.  Clinical outcomes 
were determined by measuring recession depth, recession width, probing depth, clinical 
attachment level, width of keratinized tissue and gingival thickness at baseline, 3 and 6 
months post-surgery. The results revealed that both treatment techniques showed favourable 
clinical outcomes in terms of root coverage and combination treatment provided no added 
advantage except for the increase in gingival thickness compared with the treatment with 
coronally advanced flap alone.
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Gupta et al. (2015)
 45
 investigated the adjunctive effect of Platelet rich fibrin along with 
coronally advanced flap (CAF) in the treatment of gingival recession. 26 subjects with 30 
isolated Millers class I or class II recession were treated either with coronally advanced flap 
in combination with platelet rich fibrin or with coronally advanced flap alone. Clinical 
parameters including probing pocket depth, recession depth, clinical attachment loss, 
keratinized tissue width and gingival tissue thickness were evaluated at baseline, 3 months 
and 6 months post operatively. The results of the study revealed that statistically significant 
clinical outcomes obtained for both the treatment groups in terms of root coverage without 
significant intergroup differences. They concluded that Platelet rich fibrin (PRF) provided an 
added advantage of easily wound healing and quicker attainment of optimal gingival tissue 
thickness, but the combination (PRF+CAF) did not provide any added advantage in terms of 
root coverage.
 
 
Tunali et al. (2015)
 46
 evaluated the effectiveness of L – PRF combined with coronally 
repositioned flap and compared this procedure with free connective tissue grafts in 
combination with coronally repositioned flap in the treatment of 44 multiple adjacent bilateral 
Millers Class I and II gingival recession in 10 patients. Clinical measurements such as 
gingival recession, probing depth, distance from CEJ to gingival margin, clinical attachment 
level and keratinized tissue width were measured at baseline, 6 months and 12 months after 
surgery. Connective tissue graft was obtained from the palate. The results of the study 
revealed that both treatment methods were effective in root coverage and clinical attachment 
level gain. The difference between the two techniques in terms of recession reduction and 
CAL gain were no significant and it was found that L-PRF membrane in combination with a 
coronally repositioned flap procedure is safe and effective for the treatment of Millers Class I 
and II gingival recession defects without significant morbidity or potential clinical difficulties 
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associated with donor site surgery. They have concluded that L-PRF membrane can be used 
as an alternative graft material for treating multiple adjacent recessions without the 
requirement of an additional surgery.
 
 
Shah et al. (2015)
 47
 investigated the effect of Platelet rich fibrin in the regeneration of 
periodontal intrabony defects and compared it with Demineralized freeze dried bone allograft 
in 20 patients with bilateral defects. The intrabony defects received two plugs of PRF 
prepared from patients own blood or Demineralised freeze dried bone allograft.  Clinical 
parameters such as probing depth, relative attachment level and gingival margin level were 
measured at baseline and 6 months post surgery. The results of the study revealed that 
Platelet rich fibrin showed significant improvement after 6 months which is comparable to 
Demineralized freeze dried bone allograft for periodontal regeneration. They concluded that 
Platelet rich fibrin can be used in the regeneration of periodontal intrabony defects.
 
 
Ajwani et al. (2015)
 48
 evaluated the clinical efficacy of platelet rich fibrin and open flap 
debridement in the treatment of intrabony defects. 20 subjects with forty intrabony defects 
were treated either with platelet rich fibrin with open flap debridement or with open flap 
debridement alone. Clinical parameters recorded at baseline and at 9 months postoperatively 
included plaque index, sulcus bleeding index and relative attachment level. For the 
measurement of bone defect, distances from the crest of the alveolar bone to the base of the 
defect was considered. The results revealed that a statistically significant reduction in probing 
depth and attachment gain was found in the sites treated with Platelet rich fibrin compared to 
control sites.  Similarly the adjunctive use of platelet rich fibrin with open flap debridement 
significantly improved the radiographic defect fill. The results of the study signify the role of 
platelet rich fibrin in periodontal regeneration.
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Elgendy et al. (2015)
 49
 investigated the effect of Nanocrystalline hydroxyapatite bone 
graft with or without Platelet rich fibrin membrane in the treatment of intrabony periodontal 
defects in 20 patients with bilateral identical intrabony defects. Clinical parameters such as 
probing depth, clinical attachment level and radiographic evaluation of the defect were 
recorded at baseline and at 6 months post operatively. Standardized radiographs were 
digitalized and the bone density analysis was done as grey levels measured using computer 
graphic software (Adobe Photoshop version 7). The results of the study revealed that 
Nanocrystalline hydroxyapatite bone graft in combination with platelet rich fibrin 
demonstrated significant probing pocket depth reduction, clinical attachment level gain and 
increased radiographic bone density than Nanocrystalline hydroxyapatite alone. The authors 
suggest that, the combination therapy of Platelet rich fibrin membrane with commercially 
available bone grafts can enhance the periodontal regeneration.
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MATERIALS AND METHODS 
PATIENT SELECTION 
The patients who participated in the study were out patients who visited the Department 
of Periodontology, KSR Institute of Dental Science and Research, Tiruchengode. A total of 9 
patients including both males and females aged between 20- 50 years were selected. The study 
subjects were clinically (using furcation probe) and radiographically (radiolucency in the 
furcation area) evaluated for the presence of bilateral Grade II furcation involvement according 
to the 1953 Glickman’s classification. The study protocol was approved by the Institutional 
Ethical Committee and Review Board. Written and verbal consent was obtained from the 
selected patients. All the patients included in the study satisfied the following inclusion and 
exclusion criteria. 
INCLUSION CRITERIA 
 Patients with a diagnosis of generalized chronic periodontitis.  
 Clinically detectable Grade II furcation involvement in bilateral mandibular first molars. 
 Probing depth of ≥5mm in the William’s calibrated periodontal probe and horizontal 
probing depth of ≥3mm in the Naber’s color coded probe. 
 Radiolucency in the furcation area in bilateral mandibular first molars on intraoral 
periapical radiograph. 
 Subjects who had not undergone any periodontal therapy, one year prior to the initiation 
of the study. 
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EXCLUSION CRITERIA 
 Patients with any systemic illness 
 Patients under long term medications such as corticosteroids or calcium channel blockers 
 Immunocompromised individuals 
 Patients with advanced periodontal destruction 
 Patients with poor oral hygiene even after phase I therapy 
 Pregnant and lactating women 
 Patients using tobacco in any form 
RANDOMIZATION 
Randomization of the defect site to receive the regenerative materials was done by toss of 
a coin. Test sites received Novabone putty bone graft material and Platelet rich fibrin membrane 
and control sites received Novabone putty alone. 
ARMAMENTARIUM 
ARMAMENTARIUM FOR CLINICAL EVALUATION 
1. Mouth mirror 
2. Explorer 
3. Naber’s furcation probe 
4. William’s calibrated periodontal probe 
5. Customized occlusal stents 
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ARMAMENTARIUM FOR RADIOGRAPHIC EVALUATION 
1. Intra - Oral periapical radiograph  (2 E Speed) 
2. XCP holder 
3. X - ray Digitizer 
4. Auto CAD 2015 software 
SURGICAL ARMAMAMENTARIUM 
1. Sterile surgical gloves 
2. Mouth mirror 
3. William’s calibrated periodontal probe 
4. Naber’s furcation probe 
5. Explorer 
6. Cotton pliers 
7. Sterilized cotton pellets and gauze 
8. Povidone iodine 
9. Bard Parker handle no. 3 
10. Surgical blade no. 15 
11. Straight scissors 
12. Castroviejo scissors 
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13. Set of 7 Gracey curettes 
14. Needle holder 
15. Non resorbable 3-0 black braided silk suture 
16. 2% lignocaine local anesthetic agent containing adrenaline in the ratio of 1:80,000 
17. Normal saline 
18. Coe pack 
19. NovaBone putty bone replacement graft material 
ARMAMENTARIUM FOR PRF PREPARATION 
1. PRF box 
2. Sterile glass test tube 
3. Test tube holder 
4. Sterile cotton pliers 
5. Sterile scissors 
6. Sterile surgical gloves 
7. 10ml syringe 
8. Tourniquet 
9. Table centrifuge 
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STENT PREPARATION 
Individually fabricated occlusal stents were made for the standardization of the 
measurements. Alginate impressions were made for each patient and the study models were 
prepared in type II dental plaster. Self cure acrylic was adapted over the premolar and molar area 
covering the occlusal and 1/3 of the buccal and lingual teeth surfaces. A groove was placed in an 
occluso-apical direction in the mid buccal and mid lingual area for the reproduction of the 
clinical measurements without any errors. 
CLINICAL PARAMETERS 
1. Plaque Index (Modification by Loe 1967) 
50 
2. Gingival Index (Modification by Loe 1967)
50 
3. Probing pocket depth
51 
4. Clinical attachment level
51 
5. Horizontal probing depth
17 
PLAQUE INDEX 
Plaque index was described by Silness and Loe in 1964 and modified by Loe in 1967. The scores 
and the interpretation of the plaque index are given below. 
Score  Criteria 
0 No plaque 
1 A film of plaque adhering to the free gingival margin and adjacent area of the 
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tooth. The plaque may be seen only by running a probe across the tooth 
surface. 
2 Moderate accumulation of soft deposits within the gingival pocket, on the 
gingival margin and/or adjacent tooth surface, which can be seen by the naked 
eye. 
3 Abundance of soft matter within the gingival pocket and/or on the gingival 
margin and adjacent tooth surface 
 
Calculation of plaque index: 
PI for the area: Each area (disto-facial, mesio-facial, facial and lingual) is assigned a score from 
0-3 
PI for a tooth: The scores from the four areas are calculated and divided by four 
PI score for the individual: The scores for each tooth were added and then divided by the total 
number of teeth examined. 
INTERPRETATION 
Excellent 0 
Good  0.1-0.9 
Fair 1.0-1.9 
Poor 2.0-3.0 
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GINGIVAL INDEX 
The Gingival Index (GI) was developed by Loe and Silness in 1963 and modified by Loe in 1967 
Instrument used: Mouth mirror and periodontal probe. 
 The tissues surrounding each tooth are divided into four gingival scoring units: distofacial 
papilla, facial margin, mesio-facial papilla and the entire lingual gingival margin. The teeth and 
gingiva should be dried lightly with a blast of air and /or cotton rolls. 
 Each of the 4 gingival units was assessed according to the criteria as follows: 
Score  
 
Criteria  
 
0 Absence of inflammation/normal gingiva.  
 
1 Mild inflammation: slight change in color, slight edema; no bleeding on probing  
 
2 Moderate inflammation: moderate glazing, redness, edema and hypertrophy, 
bleeding on probing.  
 
3 Severe inflammation: marked redness and hypertrophy, ulceration, tendency to 
spontaneous bleeding.  
 
 
Calculation: 
GI Score for the area: Each area (disto-facial, facial, mesio-facial, lingual) is assigned a score 
from 0 to 3. 
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GI Score for a tooth: The scores from the four areas of the tooth are added and then divided by 
four.  
GI score for the individual: The indices for each of the teeth are added and then divided by the 
total number of teeth examined. The scores range from 0 to 3.  
INTERPRETATION 
Gingival scores  
 
Condition  
 
0.1-1.0 Mild Gingivitis  
 
1.1-2.0 Moderate Gingivitis  
 
2.1-3.0 Severe Gingivitis  
 
 
Probing pocket depth was measured using a Williams’ calibrated periodontal probe in the mid 
buccal or mid lingual area with the fabricated stent in place. 
Clinical attachment level 
Clinical attachment level is the distance between the base of the pocket and a fixed point on the 
crown, such as the cementoenamel junction. 
When the gingival margin is located on the anatomic crown the level of attachment is determined 
by subtracting from the depth of the pocket the distance from the gingival margin to the CEJ. If 
both are same, the loss of attachment is zero. 
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When the gingival margin coincides with the CEJ, the loss of attachment equals the pocket 
depth. 
When the gingival margin is located apical to the CEJ, the loss of attachment is greater than the 
pocket depth and therefore the distance between the CEJ and the gingival margin is added to the 
pocket depth. 
Horizontal probing depth at furcation defect was measured using a color coded graduated 
Nabers’s probe marked at 3 mm intervals. For a reference, a tangent to the eminences of the 
roots adjacent to the scored furcation was used. 
RADIOGRAPHIC PROCEDURE 
Intra-oral periapical radiographs were taken using long cone paralleling angle technique. 
Study subjects were made to wear lead apron and thyroid collar before x – ray exposure. 
Subjects were then positioned upright in the chair with proper back support. The x ray unit 
settings for the Kvp, mA and tube head angulations were adjusted according to the region of 
interest. X rays taken were developed and digitalized. 
RADIOGRAPHIC PARAMETER 
Intra oral periapical radiographs were taken at baseline and 6 months after treatment. 
Digitalized radiographs were evaluated using Auto CAD 2015 software. 
PRF PREPARATION PROTOCOL
26 
Platelet rich fibrin was prepared according to the protocol developed by Choukroun et al 
in the year 2001. Prior to the surgery 10ml of intravenous blood was collected from the patient’s 
antecubital vein and transferred into a sterile glass test tube without any anticoagulant. The test 
                                                                                                                       Materials and Methods 
 
37 
 
tube was then placed in the centrifuge machine immediately and centrifuged for 10 minutes at 
3000rpm. Blood centrifugation resulted in the separation of the blood components into three 
layers. Platelet poor plasma is collected in the topmost layer and the bottom layer is the RBC 
base. The layer between these two is the fibrin clot into which all the platelets were trapped. PRF 
clot was retrieved from the test tube using sterile tweezers and then separated from the 
underlying RBC base using a sterile scissors preserving some amount of RBC. The separated 
PRF clot was then placed on the grid of PRF preparation box and covered with compressor lid, 
which gives a PRF membrane of constant thickness. 
PRE SURGICAL THERAPY 
Surgical intervention  of  the furcation defects were carried out after complete scaling and 
root planing with proper oral hygiene instructions. After phase I therapy the patients were kept in 
maintenance phase for a period of 6-8 weeks and re-evaluated to confirm the suitability of the 
sites for the surgery. The test site and the control sites were clinically and radiographically 
evaluated at baseline and at 6 months post treatment.  
SURGICAL PROTOCOL 
Intraoral and extraoral antisepsis was maintained using povidone iodine. After 
administrating local anesthesia and achieving proper anesthesia, intrasulcular and interdental 
incisions were carried out buccally and lingually. Full thickness mucoperiosteal flap was 
elevated and meticulous root debridement and curettage was done using area specific Gracey 
curettes. The furcation defect was thoroughly examined for any residual embedded calculus. The 
surgical area was irrigated with sterile normal saline. Pre-suturing was done prior to grafting 
using non resorbable 3-0 black braided silk. Test site received placement of bone graft 
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(Novabone Putty) and PRF membrane. The graft was gently packed into the furcation area until 
the defect is filled and overfilling was avoided. The graft was then covered subsequently by the 
prepared PRF membrane. The PRF membrane was adapted in such a way that it covers at least 
3mm beyond the furcation defect. Control site also received the identical treatment except for the 
PRF membrane. The surgical sites were protected with periodontal pack. 
POST OPERATIVE CARE 
Suture and periodontal dressing were removed one week after surgery. The operated area 
was rinsed carefully with normal saline. Gentle brushing with a soft brush was recommended. 
Oral hygiene maintenance was reinforced in all the patients. The patients were recalled every one 
week for one month and 6 months post operatively. All the clinical measurements and 
radiographs were repeated at the end of the 6
th
 month. 
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ARMAMENTARIUM FOR CLINICAL EVALUATION 
 
 
ARMAMENTARIUM FOR RADIOGRAPHIC EVALUATION 
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ARMAMENTARIUM FOR PRF PREPARATION 
 
 
 
ARMAMENTARIUM FOR SURGICAL PROCEDURE 
 
 
 
                                                                                                                       Materials and Methods 
 
41 
 
 
PRF PREPARATION PROCEDURE 
 
        
    Drawing of 10ml blood                      Centrifugation                           After centrifugation 
 
     
Separating supernatant serum        Retrieving buffy coat             Separating buffy coat from RBC 
 
    
PRF clot placed in the PRF             PRF clot covered with lid            Prepared PRF membrane 
     preparation box                               for compression    
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                                SURGICAL PROCEDURE – CONTROL SITE 
 
1  
                 Pre-op                           Pre-op vertical probing depth   Pre-op horizontal probing depth 
 
 
        Grade II Furcation                     Placing Bone Graft                   Interrupted sutures placed 
 
 
           Post-op 6 months           Post-op vertical probing depth    Post-op horizontal probing depth      
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SURGICAL PROCEDURE – TEST SITE 
 
   
                 Pre-op                          Pre-op vertical probing depth    Pre-op horizontal probing depth 
 
               
         Grade II Furcation                       Placing bone graft                     PRF membrane placed 
             
     
           Post-op 6 months            Post-op vertical probing depth   Post-op horizontal probing depth      
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PRE AND POST OPERATIVE RADIOGRAPHS 
 
 
                          
  Pre-operative radiograph –Control                            Post-operative radiograph – Control                               
 
 
                           
    Pre-operative radiograph – Test                                Post-operative radiograph – Test                               
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STATISTICAL ANALYSIS 
PAIRED t TEST: 
Paired t test is applied when there is a pair of data from single element in an observation. 
Data are collected before and after the intervention, so that the same group acts as both case and 
control. Then the mean of both the groups are compared to get the t value. 
ANCOVA test: 
This analysis is used as a procedure for the statistical control of an uncontrolled variable 
in an experiment. The influence of the uncontrolled variable is usually removed by simple linear 
regression method and the residual sums of squares are used to provide variance estimates. 
P value: 
The P value or calculated probability is the estimated probability of rejecting the null 
hypothesis of a study question when that hypothesis is true. Differences between the two 
populations were considered significant when p < 0.05. 
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RESULTS 
The present study was undertaken to evaluate the effectiveness of platelet rich fibrin in 
augmenting the regenerative effect of Novabone putty in the treatment of furcation defects. A 
total of 18 Grade II furcation defects in 9 patients were treated with Novabone putty and PRF( 
test group) or with Novabone putty alone (control group). There was no attrition during follow 
up and scheduled maintenance visits. Clinical and radiographic evaluations were performed pre-
operative and repeated 6 months post-operative. Both grafting materials were found to be well 
tolerated and the surgical sites healed without any complications. 
Table 1 and Graph 1 show the comparison of the clinical and radiographic parameters 
before intervention in the test and control groups. 
A non significant p-value on comparing the mean values of all the selected clinical and 
radiographic parameters reveals that before intervention two groups were similar. 
Table 2 and Graph 2 show the comparison of the clinical and radiographic parameters in 
the sites treated with Novabone putty alone from baseline to 6 months. 
The mean plaque index and gingival index scores before intervention were 2.55 and 2.30 
respectively. Six months post intervention shows a significant reduction in the plaque and 
gingival index score to 0.63 and 0.58 respectively. 
Grafting with Novabone putty resulted in significant probing pocket depth reduction from 
6.00 mm to 3.56 mm and a significant gain in clinical attachment level from 6.11mm at baseline 
to 5.00 mm at 6 months post intervention. Similarly mean horizontal probing depth also showed 
a significant reduction from 5.33 mm to 2.33 mm. There was a statistically significant reduction 
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in the mean radiographic vertical defect depth from baseline (2.5688mm) to 6 months 
(1.3587mm). 
Table 3 and Graph 3 show the comparison of the clinical and radiographic parameters in 
the sites treated with Novabone putty + PRF from baseline to 6 months. 
The mean plaque index and gingival index scores before intervention were 2.39 and 2.28 
respectively. Six months post intervention shows a significant reduction in the plaque and 
gingival index score to 0.55 and 0.61 respectively. 
Grafting with Novabone putty and PRF resulted in significant probing pocket depth 
reduction from 6.00 mm to 3.00 mm and a significant gain in clinical attachment level from 
6.11mm at baseline to 4.00 mm at 6 months post intervention. Similarly mean horizontal probing 
depth also showed a significant reduction from 5.11mm to 2.11mm. 
There was a statistically significant reduction in the mean radiographic vertical defect 
depth from baseline (2.015mm) to 6 months (1.1177mm). 
  Table 4 and Graph 4 shows the comparison of the clinical and radiographic parameters 
between the test and the control groups at 6 months post operatively. 
The mean score values for the test and control group in terms of plaque index were 0.55 
and 0.63 and for the gingival index the mean score values were 0.611 and 0.58 respectively. The 
non significant p – value indicates that no significant improvement occurred for the test group 
compared to the control group at the end of six months. 
There was no statistically significant difference in the mean probing depth between the 
test group (3.00mm) and the control group (3.56mm). Comparing the mean value for the clinical 
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attachment level and horizontal probing depth between the group was found to be non significant 
at the end of six months. 
Similarly, the mean radiologic vertical defect fill at the end of six months for the test 
group (0.897mm) when compared with the control group (1.210mm) also showed a non 
significant p- value. 
The non significant p – value obtained on comparing the mean values of all clinical and 
radiographic parameters reveals that both the intervention at the end of six months were equally 
effective. 
Table no. 5 shows the comparison of the mean plaque index at the end of the sixth month 
between the test group and control group.  Table no.4 indicates that both the groups are equally 
effective. The initial plaque level might have influence on the post plaque level, though the mean 
values are similar before intervention.  We used ANCOVA test to compare the mean plaque 
index score at the end of the sixth month after controlling the plaque index score before 
intervention.  The non-significant p-value of the “before intervention” infers that initial plaque 
index score has no influence on the plaque index score at the end of sixth month. The non-
significant p-value of the “Group" infers that even after controlling the initial plaque level, the 
two groups are equally effective in reducing the plaque level. 
Table no.6 shows the comparison of mean gingival index at the end of the sixth months 
between the test and control groups after controlling the gingival index before intervention. The 
ANCOVA test has revealed a non-significant p-value  “Before intervention” which infers that 
gingival index before intervention has no influence on the gingival index values at the end of the 
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sixth month and the non-significant p-value of the “Group” infers that both the groups are 
equally effective even after controlling the gingival level before intervention. 
Table no.7 shows the comparison between the mean probing depth at the end of the sixth 
month after controlling with the probing depth level before intervention. The significant p-value 
of “Before intervention” infers that probing depth level before intervention has influence on the 
probing depth level at the end of the sixth month and the non-significant p-value of the “Group” 
infers that even after controlling the baseline probing depth level, the mean reduction occurred 
for  both group was similar. i.e., both the interventions are equally effective. 
Table no.8 shows the comparison of mean clinical attachment loss between the two 
groups at the end of sixth month after controlling with the CAL before intervention.  The 
significant p-value of the “Group” infers that mean CAL has been significantly different for the 
two groups at the end of sixth month.  In the test group the reduction in the CAL has been higher 
compared to the control group. Further, the significant p-value “Before intervention” infers that 
CAL value at the end of sixth month has been highly influenced by the CAL values before the 
intervention in both the groups. 
Table no.9 shows the comparison of mean horizontal probing depth of the two groups at 
the end of the sixth month after controlling with the horizontal pocket depth before intervention.  
The ANCOVA test result infers that there is no significant difference exists between the two 
groups with respect to the horizontal pocket depth level at the end of sixth month. The significant 
p-value of “Before intervention” infers that horizontal probing depth level before intervention 
has influence on the probing depth level at the end of the sixth month. 
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Table no.10 shows the comparison of mean vertical probing depth at the end of sixth 
month after controlling with the vertical probing depth level before intervention.  The significant 
p-value of “Before intervention” infers that Vertical probing depth before intervention has been 
highly influenced the sixth month values, for both the groups.  The non-significant p-value of 
“Group” infers that the two groups vertical probing depth has been similar at the end of the sixth 
month after the intervention, even after controlling with the before intervention values. 
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Table 1: Mean and SD of clinical parameters before treatment by group wise 
Variable Test  group Control group T-test 
value 
Degrees 
of 
freedom 
P-value 
Mean SD Mean SD 
Plaque 
Index 
2.3889 .6859 2.5556 .3254 -0.659 16 0.520 
Gingival  
index 
2.2778 .1954 2.3056 .3004 -0.232 16 0.819 
Probing 
Depth 
6.00 .707 6.00 .707 --   
Clinical 
attachment 
level 
6.11 .782 6.11 .601 ---   
Horizontal 
Probing 
depth 
5.11 .782 5.33 .707 -0.632 16 0.536 
Radiological 
vertical  
defect depth 
2.0150 .8004 2.5688 .8237 -1.446 16 0.167 
 
Graph 1 
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Table 2: Mean and standard deviation of the clinical and radiographic parameter at baseline and 
at 6
th
 month for sites treated with Novabone putty alone (control group) 
Variable Baseline At the end of 6
th
 month Paired  t-
test value 
P-value 
Mean SD Mean SD 
Plaque 
Index 
2.5556 0.3254 0.6389 0.2826 10.553 <0.001 
Gingival  
index 
2.3056 0.3004 0.5833 0.2795 12.218 <0.001 
Probing 
Depth 
6.00 0.707 3.56 0.726 10.094 <0.001 
Clinical 
attachment 
level 
6.11 0.601 5.00 0.866 5.547 0.001 
Horizontal 
Probing 
depth 
5.33 0.707 2.33 0.866 18.000 <0.001 
Radiological 
vertical  
defect depth 
2.5688 0.8237 1.3587 0.6435 4.491 0.002 
 
Graph 2 
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Table 3: Mean and standard deviation of the clinical and radiographic parameter at baseline and 
at 6
th
 month for sites treated with Novabone putty and PRF (test group) 
Variable Baseline At the end of 6
th
 month Paired  t-
test value 
P-value 
Mean SD Mean SD 
Plaque Index 2.3889 0.6859 0.5556 0.3004 7.659 <0.001 
Gingival  
index 
2.2778 0.1954 .6111 0.2826 13.333 <0.001 
Probing 
Depth 
6.00 0.707 3.00 1.000 12.728 <0.001 
Clinical 
attachment 
level 
6.11 0.782 4.00 1.500 5.429 0.001 
Horizontal 
Probing 
depth 
5.11 0.782 2.11 0.928 10.392 <0.001 
Radiological 
vertical  
defect depth 
2.0150 0.8004 1.1177 0.3921 4.640 0.002 
 
Graph 3 
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Table 4: Intergroup comparison of the Mean and SD of clinical and radiographic parameters after 
intervention 
 
Graph 4 
           
0.5556
0.6111
3
4
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Plaque Index
Gingival  index
Probing Depth
Clinical attachment level
Horizontal Probing depth
Radiological defect depth fill
Novabone Novabone+PRF
Comparision  between the two groups after intervention
Variable 
Test  group Control group T-test 
value 
Degrees of 
freedom 
P-
value 
Mean SD Mean SD 
Plaque Index 0.5556 0.3004 0.6389 0.2826 -0.606 16 0.553 
Gingival  index 0.6111 0.2826 0.5833 0.2795 0.210 16 0.837 
Probing Depth 3.00 1.000 3.56 0.726 -1.348 16 0.196 
Clinical attachment 
level 
4.00 1.500 5.00 0.866 -1.732 16 0.102 
Horizontal Probing 
depth 
2.11 0.928 2.33 0.866 -0.525 16 0.607 
Radiological defect 
depth fill 
0.897 0.580 1.210 0.808 -.876 16 0.407 
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Table no.5: Comparison of Mean Plaque index score at the end of sixth month by group wise 
after controlling with the plaque index score before intervention. 
Plaque Index Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 0.5556 0.3004 Before intervention 0.168 0.687 
Control group 0.6389 0.2826 Group 0.421 0.526 
 
Table no.6: Comparison of Mean Gingival index score at the end of sixth month by group wise 
after controlling with the gingival index score before intervention. 
Gingival  Index Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 0.6111 0.2826 Before intervention 0.204 0.658 
Control group 0.5833 0.2795 Group 0.032 0.861 
 
Table no.7: Comparison of Mean Probing depth level at the end of sixth month by group wise 
after controlling with the Probing Depth level before intervention. 
Probing Depth 
level 
Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 3.00 1.000 Before intervention 8.741 0.010 
Control group 3.56 0.726 Group 2.698 0.121 
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Table no.8: Comparison of Mean Clinical Attachment level at the end of sixth month by group 
wise after controlling with the Clinical attachment level before intervention. 
Clinical 
Attachment 
level 
Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 4.00 1.500 Before intervention 11.498 0.004 
Control group 5.00 0.866 Group 4.968 0.042 
 
Table no.9: Comparison of Mean Horizontal Probing Depth level at the end of sixth month by 
group wise after controlling with the Horizontal Probing Depth level before intervention 
Horizontal 
Probing Depth 
level 
Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 2.11 0.928 Before intervention 10.607 0.005 
Control group 2.33 0.866 Group 0.022 0.885 
 
Table no.10 : Comparison of Mean  Radiographic Vertical defect depth level at the end of sixth 
month by group wise after controlling  with defect depth level before intervention. 
Radiographic 
Vertical defect 
depth 
Mean SD ANCOVA test result 
Source F-value  P-value 
Test  group 1.1177 00.3921 Before intervention 5.508 0.033 
Control group 1.3587 .6435 Group 0.050 0.826 
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DISCUSSION 
Among the various periodontal defects, management of furcation involvement is the most 
difficult and complex, because of the anatomical characteristics and morphological structure. 
The ultimate goal of furcation therapy is to completely close the furcation, thereby returning 
tooth to anatomic normalcy, facilitating long term maintenance and thus improving the 
likelihood of tooth retention. Periodontal reconstructive therapy is the ideal since it can restore 
the function and structure of gingiva, alveolar bone, cementum and periodontal ligament. 
Bone grafting has been widely used in reconstructive periodontal surgery, to fill osseous 
defects and enable regeneration. Alloplastic bone graft substitutes in osseous regeneration have 
been evaluated for several years and bioactive glass is one such alloplastic material with 
osteostimulatory and osteoconductive properties.
 
In our study we have used Novabone putty 
which is a moldable, premixed composite of bioactive calcium-phospho-sliscate particulate.
 
We used a second generation platelet concentrate, defined as an “autologous leukocyte 
and platelet rich fibrin biomaterial” to obtain a physical fibrin barrier membrane to selectively 
guide cell proliferation and tissue expansion and help in the regenerative process. The unique 
structure of the PRF membrane act as a vehicle in carrying cells and growth factors, that are 
essential for periodontal regeneration. 
In this study, we have treated 9 patients with bilateral grade II furcation invasion. The 
selection of the sites for treatment was restricted to mandibular first molars alone, considering 
the fact that the differences in root morphology among teeth can influence the treatment 
outcome. The test sites were treated with novabone putty with PRF and the control sites with 
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novabone putty alone with an aim to evaluate the additional benefits on regeneration of furcation 
defects on adding PRF. In order to avoid bias we have randomized the sites by coin toss method. 
In our study, the control sites were treated with novabone putty bone graft alone. We 
observed a significant improvement in all the clinical parameters such as plaque index, gingival 
index, probing depth, CAL, horizontal probing depth and significant radiographic defect fill from 
baseline to 6 months. 
The result of the present study is in accordance with findings of the studies done by 
Humagain et al. (2007)
17
 and Anderegg et al. (1999)
9
 where they observed a significant 
improvement in clinical and radiographic parameters in furcation defects treated with bioactive 
glass. 
Similar improvements were observed by Froum et al. (1998)
6
 and Grover et al. (2013)
35
 
in intrabony defects. The above studies are a clear evidence to the regenerative potential of 
bioactive glass. 
Whereas, Ong et al. (1998)
8
 and Chacko et al. (2014)
43
 treated intrabony defects with 
bioactive glass and obtained only a slight improvement in clinical and radiographic parameters 
compared to open flap debridement alone. They infer the reasons for the lack of significant 
difference between the groups to the wide particle size range of bioactive glass, difference in the 
defect selection, methods of measurement and data analysis. 
On the contrary, Dybvik et al (2007)
20 
observed no significant beneficial effect in clinical 
and radiographic parameters when intrabony defects  were treated with bioactive glass over open 
flap debridement alone, which they attributed to the selection of the teeth with deep intra-osseous 
defects, severe bone loss and hypermobility. 
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We treated the test sites with a combination of PRF with novabone putty bone graft.  
A combination of bioactive glass with e-PTFE (Nevins et al
10 
and Yukna et al
11
), 
bioabsorbable membrane (Mengel et al
13
) and with enamel matrix derivative (Pontes et al
14 
and 
Kuru et al
16
) have been found to demonstrate synergistic regenerative potential. 
The regenerative effect of PRF in furcation defects has been proved by the studies done 
by Bajaj el al. (2013)
37
 and Sharma et al. (2011)
26
. Similarly, Pradeep et al. (2012)
30
, Sharma et 
al. (2011)
27 
and Ajwani et al. (2015)
48
 found significant improvement when PRF was used in 
intrabony defects. 
Also, a synergistic effect of PRF with several bone graft materials in periodontal 
regeneration has also been demonstrated by Shah et al. (PRF+DFDBA)
47
, Elgendy et al. (PRF+ 
nanocrystalline hydroxyapatite)
49
, Bansal et al. (PRF+DFDBA)
38
 and Pradeep et al. (PRF+ 
porous hydroxyapatite graft).
31
  
Considering the fore mentioned regenerative potential of Novabone putty and PRF and 
the potential benefits of combination therapy we treated the test sites with novabone putty and 
PRF. 
Six month post surgery evaluation showed significant improvement in all the clinical and 
radiographic parameters. 
We could not access any published dental literature till date that evaluated the combined 
effect of Novabone putty (bioactive glass) along with PRF in the treatment of furcation defects. 
Comparison between the sites treated with novabone putty alone and novabone putty with 
PRF at the end of 6 months showed no statistically significant difference in any of the clinical 
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and radiographic parameters investigated. But comparison of mean clinical attachment level 
between the two groups at the end of six month after controlling with the CAL before 
intervention reveals a gain in CAL in the PRF + Novabone treated group compared to the control 
group which clearly indicates a true periodontal regeneration via new attachment. 
Due to lack of available published studies on the use of PRF and bioactive glass we were 
not able to compare and analyze our study. 
Our inability to demonstrate any remarkable supplemental effect of PRF on Novabone 
putty can be attributed to certain limitations of our study. 
We have used a 2D radiographic technique using AutoCAD software, which gives 
measurement in sub-millimetric scale, to evaluate grade II furcation
52
. Even though this 
conventional radiographic technique is simple and non invasive, it is not possible to measure the 
horizontal depth of the defect by a 2D imaging
53
. In addition radiography does not reflect the 
actual stage of healing and may underestimate the final process of healing. At the same time, a 
3D imaging could have given more accurate results, which we were not able to carry out due to 
its unavailability in our institution of study. 
Though surgical re-entry or histologic evaluation is considered to be gold standard to 
assess true regeneration, we were unable to perform it due to ethical barrier and lack of patient 
co-operation. 
Among the defects treated more than half were located lingually, and we found it difficult 
to access the lingual furcation for debridement of the root surfaces. We also encountered 
difficulty during placement of bone graft and PRF membrane, which could have adversely 
influenced the treatment outcome. 
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The small sample size of our study too had an impact on the outcome. The study 
population was limited in number because, we restricted the selection of the furcation defects to 
mandibular first molars alone, keeping in mind that tooth morphology varies among teeth and 
can influence regeneration. A relatively smaller number of patients in the study may have 
resulted in the lack of any detectable difference between the groups. 
We have evaluated the regenerative outcome at 6 months post surgery. Lovelace et al. 
(1998)
4 
found that bioactive glass particles are not completely integrated at 6 months. Therefore, 
the shorter duration of the study might have influenced the results. 
Further studies with a longer duration, large sample size, better imaging techniques, 
variety of teeth with different morphologies and different degree of furcation involvement must 
be undertaken, to determine the beneficial effects of the adjunctive use of PRF with bioactive 
glass, before arriving into a definitive conclusion. 
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SUMMARY AND CONCLUSION 
From the results of the study we arrive at the following conclusions: 
 Novabone putty is clinically effective in the reconstructive therapy of furcation defects. 
 A combination therapy with bioactive glass + PRF is also found to be effective. 
 There is no significant difference in the clinical outcomes between a monotherapy of 
bioactive glass and a combination therapy of bioactive glass + PRF. 
 Among the clinical parameters assessed, a higher gain in CAL in the combination therapy 
reveals new attachment. 
From the findings of the study we summarize that, bioactive glass alone and a combination of 
bioactive glass + PRF are efficacious in the treatment of grade II furcation defects. We found 
beneficial effects of adding PRF to Novabone putty in terms of gain in CAL signifying 
regeneration, though radiographic evidence of bone fill could not be elicited. Considering the 
limitations of our study, further studies are warranted. 
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ANNEXURE 1 
 
INFORMATION SHEET 
 
We are conducting a study on CLINICAL AND RADIOLOGICAL EVALUATION OF 
NOVABONE PUTTY WITH PRF MEMBRANE FOR THE TREATMENT OF GRADE II 
FURCATION INVOLVEMENT- A RANDOMIZED CONTROLLED TRIAL. 
The identity of the patients participating in the research will be kept confidential 
throughout the study. In the event of any publication or presentation resulting from the research, 
no personally identifiable information will be shared.  
Taking part in the study is voluntary. You are free to decide whether to participate in the 
study or to withdraw at any time; your decision will not result in any loss of benefits to which 
you are otherwise entitled.  
The results of the special study may be intimated to you at the end of the study period or 
during the study if anything is found abnormal which may aid in the management or treatment.  
 
 
  
Name of the patient                                                                    Signature / Thumb impression  
 
 
Name of the investigator                                                                          Signature  
Date 
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                                               ANNEXURE 2 
                                        INFORMED CONSENT FORM 
Clinical and radiological evaluation of Novabone Putty with Platelet rich fibrin (PRF) membrane 
for the treatment of Grade II furcation involvement- A randomized controlled trial 
Name:                                       Age/Sex                                Op.No:                   Date: 
Address: 
I, _________________ aged ____________ have been informed about my role in the study. 
1.  I agree to give my personal details like name, age, sex, address, previous dental history 
& the details required for the study to the best of my knowledge. 
2. I will co-operate with the dentist for my intra oral examination & extra oral examination. 
3. I will follow the instructions given to me by the doctor during study. 
4. I permit the dentist to take blood sample, photos, intraoral radiographs & I accept to 
undergo bone regenerative procedures as required for the study. 
5. If unable to participate into study for reasons unknown, I can withdraw from the study. 
In my full consciousness & presence of mind, after understanding all the procedures in my 
own language, I am willing & give my consent to participate in this study. 
Name of the patient:                                                                     Name of the investigator:                                                                      
 
Signature/Thumb impression                                                                   Signature 
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Muha;r;rpxg;g[jy; fojk; 
 
bgah;  :      njjp : 
taJ  :      g[wnehahspvz;  : 
ghypdk; :      Muha;r;rpnrh;f;ifvz; : 
 
fPH;f;fhzg;gLk; epge;jidfSf;Fehd; xg;g[jy; mspf;fpnwd; 
1. vd; bgah;/ taJ/ ghypdk;/ Kfthp/ gy; rk;ke;jg;gl;lrpfpr;irkw;Wk; vd;Dila KG 
tptuj;jpidbfhLf;fehd; KG kdJld; xg;g[f;bfhs;fpnwd;. 
2. vd;Dilathapd; cs;gFjp (my;yJ) btspgFjpiakUj;Jth; 
ghpnrjidbra;axj;JiHf;fpnwd;. 
3. ehd; kUj;Jth; mspf;Fk; tpjpKiwfisjtwhky; filgpog;ngd;. 
4. nkw;bfhz;lMuha;r;rpf;fhfvd; ,uj;jk;/ g[ifg;glk;/ gw;fs; rk;ge;jg;gl;lvf;!;nu kw;Wk; <W 
mWitrpfpr;irvLf;fkUj;JtUf;FmDkjpmspf;fpnwd;. 
5. ehd; nkw;fz;lMuha;r;rpapy; g|;F bgwKoatpy;iyvd;why;/ Muha;r;rpapy; 
,Ue;Jtpyfpf;bfhs;ntd;. 
kUj;Jthpd; Muha;r;rprk;ke;jg;gl;ltptu|;fisKGikahf g[hpe;Jbfhz;lgpwF/ vd; KG 
kdJlDk; kw;Wk; Ra epidt[lDk; ,e;jkUj;JtMuha;r;rpapy; g|;F bfhs;srk;kj;jpf;fpnwd;. 
 
 nehahspapd; bgah;      ifbahg;gk; 
 
 Muha;r;rpahshpd; bgah;     ifbahg;gk; 
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ANNEXURE 3 
CLINICAL AND RADIOLOGICAL EVALUATION OF NOVABONE PUTTY WITH PRF 
MEMBRANE FOR THE TREATMENT OF GRADE II FURCATION INVOLVEMENT- A 
RANDOMIZED CONTROLLED TRIAL 
 
CLINICAL PROFORMA 
 
Case No: 
 
Name:                                                                                   Ph. No:                                          
Age/sex:                                                                               Op No: 
Address:                                                                               Date: 
 
Chief Complaint: 
 
Medical History: 
 
Dental History: 
 
Family history: 
 
Personal history: 
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                            CLINICAL PARAMETERS - AT BASELINE          Date: 
 
PLAQUE INDEX 
 17 16 15 14 13 12 11 21 22 23 24 25 26 27 
 
BUCCAL 
                                          
 
PALATAL 
              
 
LINGUAL 
                                          
 
BUCCAL 
              
 47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                                                                                                                PI SCORE: 
GINGIVAL INDEX 
 17 16 15 14 13 12 11 21 22 23 24 25 26 27 
 
BUCCAL 
                                          
 
PALATAL 
              
 
BUCCAL 
                                          
 
LINGUAL 
              
 47 46 45 44 43 42 41 31 32 33 34 35 36 37 
                                                                                                                               GI SCORE: 
PROBING DEPTH & CLINICAL ATTACHMENT LEVEL 
TOOTH NUMBER 
VERTICAL PROBING 
DEPTH 
HORIZONTAL PROBING 
DEPTH 
CLINICAL ATTACHMENT 
LEVEL 
TEST 
 
 
 
 
 
 
 
 
CONTROL 
 
 
 
 
 
 
 
 
SIGNATURE OFTHE GUIDE: 
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                                       CLINICAL PARAMETERS - AT 6 MONTHS               Date: 
 
PLAQUE INDEX 
 17 16 15 14 13 12 11 21 22 23 24 25 26 27 
 
BUCCAL 
                                          
 
PALATAL 
              
 
LINGUAL 
                                          
 
BUCCAL 
              
 47 46 45 44 43 42 41 31 32 33 34 35 36 37 
 
GINGIVAL INDEX 
 17 16 15 14 13 12 11 21 22 23 24 25 26 27 
 
BUCCAL 
                                          
 
PALATAL 
              
 
BUCCAL 
                                          
 
LINGUAL 
              
 47 46 45 44 43 42 41 31 32 33 34 35 36 37 
 
PROBING DEPTH & CLINICAL ATTACHMENT LEVEL 
TOOTH NUMBER 
VERTICAL PROBING 
DEPTH 
HORIZONTAL PROBING 
DEPTH 
CLINICAL ATTACHMENT 
LEVEL 
      TEST 
 
 
 
 
 
 
 
 
   CONTROL 
 
 
 
 
 
 
 
 
  SIGNATURE OF THE GUIDE: 


